Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chatham Biotec is a specialized life sciences company focused on the production and supply of high-purity agarose and agar products. Headquartered in Canada with primary manufacturing operations in Chile, the company utilizes sustainably harvested seaweed to produce a variety of agarose resins essential for molecular biology applications, including DNA and protein electrophoresis. Their product portfolio serves a global customer base across academic research, clinical diagnostics, and industrial biotechnology sectors. Chatham Biotec is recognized for its expertise in the extraction and purification of seaweed-derived polysaccharides, providing critical reagents that support genomic and proteomic workflows. The company operates under the name Chatham Industries S.A. for its Chilean manufacturing activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chatham Industries.